2. Materials and Methods This study was approved by the Institutional Review Board. 2.1. Participants This retrospective study included 11 patients with complex hindfoot pathologies, including talar osteonecrosis, failed TAR, and osteomyelitis, who underwent TTC arthrodesis using talar allografts between January 2020 and November 2022.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile